Improving surveillance for Barrett's oesophagus: AspECT and BOSS trials provide an evidence base
- 22 June 2006
- Vol. 332 (7556) , 1512.1-1512
- https://doi.org/10.1136/bmj.332.7556.1512
Abstract
Footnotes Competing interests None declared.This publication has 1 reference indexed in Scilit:
- Re: Cost-Effectiveness of Aspirin Chemoprevention for Barrett's EsophagusJNCI Journal of the National Cancer Institute, 2004